AIDA at ESMO GI Congress and DiCE’s Masterclass

AIDA proudly participated in the ESMO Gastrointestinal Cancers Congress and the Digestive Cancers Europe Masterclass, joining leading clinicians, researchers, and patient advocates to discuss the future of digestive cancer prevention.

At the event, the AIDA consortium showcased the development of its AI-powered diagnostic assistant designed to help clinicians identify precancerous gastric inflammation earlier and with greater precision. The tool aims to support personalised monitoring and guide treatment decisions that could prevent gastric cancer before it develops. These discussions underscored AIDA’s commitment to working alongside the European cancer community to deliver innovative, evidence-based solutions that improve patient outcomes.

Share

You might also be interested in

en

AIDA Publishes Major AI Breakthrough in Nature Communications

AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.

en

DiCE Hosts ENTERO Policy Event at the European Parliament

On April 24th, Digestive Cancers Europe (DiCE), a partner of the AIDA consortium, organised the ENTERO Policy Event at the European Parliament. The event brought together policymakers, clinicians, researchers, and patient advocates to highlight a growing concern in Europe: the rise of early-onset digestive cancers, including colorectal and gastric cancer.

events

AIDA General Assembly Meeting 2025

On the 24th and 25th of March, the AIDA Consortium gathered in London for the AIDA General Assembly 2025. Hosted by Imperial College London, the two-day meeting brought together leading experts and project partners to discuss the latest advancements in AI-driven gastric cancer research. The assembly commenced with a warm welcome from INCLIVA and Imperial College London, setting the stage